In making the announcement, Cutler noted that Hofseth has done a remarkable job leading the college’s research effort while serving as the interim associate dean for research since 2021.
“As an accomplished independent, extramurally funded investigator, he has shared his talents with the rest of our faculty. He has fostered a culture of advancing research by removing barriers to write stronger and more competitive grant applications by our college,” Cutler says. “It is clear that he will continue to foster collaborations, advance opportunities, and expand training of our team. Because of the strong leadership he exhibited as our interim, he became a clear choice to lead this aspect of our college.”
It is clear that [Dr. Hofseth] will continue to foster collaborations, advance opportunities, and expand training of our team.
Stephen J. Cutler, Ph.D. Dean, College of Pharmacy
Hofseth came to USC after four years at the Laboratory of Human Carcinogenesis at the National Cancer Institute in Maryland. He has published over 90 times in peer-reviewed journals, generated more than $7 million in extramural funding, and founded two companies. His research revolves around chronic inflammation and cancer.
Hofseth currently leads the R21 Bootcamp which is designed to help junior faculty better understand the process of grant applications in hopes of furthering their ability to successfully apply for future grants in aiding their research.
“I am grateful for the opportunity to serve our great COP Pharmily and to give everyone the best opportunity to thrive in research activities,” says Hofseth. “Important to this objective is removing barriers to the daunting task of grant submissions and fostering exciting ideas and collaborations - with the goal of garnering funds to move their idea phase to their discovery phase.”
Hofseth’s appointment took effect February 1, 2022.